Syndax Pharmaceuticals (SNDX) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to 0.21.
- Syndax Pharmaceuticals' Equity Ratio fell 7569.1% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year decrease of 7569.1%. This contributed to the annual value of 0.4 for FY2024, which is 5603.94% down from last year.
- According to the latest figures from Q3 2025, Syndax Pharmaceuticals' Equity Ratio is 0.21, which was down 7569.1% from 0.26 recorded in Q2 2025.
- Over the past 5 years, Syndax Pharmaceuticals' Equity Ratio peaked at 0.95 during Q1 2023, and registered a low of 0.21 during Q3 2025.
- In the last 5 years, Syndax Pharmaceuticals' Equity Ratio had a median value of 0.89 in 2022 and averaged 0.77.
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 6035.38% in 2021, then crashed by 7569.1% in 2025.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Equity Ratio stood at 0.91 in 2021, then rose by 3.51% to 0.94 in 2022, then dropped by 3.81% to 0.9 in 2023, then plummeted by 56.04% to 0.4 in 2024, then crashed by 47.38% to 0.21 in 2025.
- Its last three reported values are 0.21 in Q3 2025, 0.26 for Q2 2025, and 0.34 during Q1 2025.